Maravai LifeSciences
MRVI
MRVI
204 hedge funds and large institutions have $1.35B invested in Maravai LifeSciences in 2023 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 97 increasing their positions, 55 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
8% less funds holding
Funds holding: 221 → 204 (-17)
15% less capital invested
Capital invested by funds: $1.58B → $1.35B (-$231M)
35% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 46
Holders
204
Holding in Top 10
3
Calls
$3.12M
Puts
$1.78M
Top Buyers
| 1 | +$40.4M | |
| 2 | +$35.3M | |
| 3 | +$31M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$21.7M |
| 5 |
Holocene Advisors
New York
|
+$21.5M |
Top Sellers
| 1 | -$30M | |
| 2 | -$21.6M | |
| 3 | -$19.1M | |
| 4 |
Two Sigma Investments
New York
|
-$18.2M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14.8M |